EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel C-glycosyl Pyranose-Based Sulfonium and Selenonium Salts Targeting α-Glucosidase with Potent Antihyperglycemic Activity

Jiahui Zhou, Shuqing Jin, Jiahao Yi, Yaojia Li, Wenxiang Tao, Yu Li, Zhimei Wang iD, Wei Li iD, Hulin Jiang, Genzoh Tanabe iD, Osamu Muraoka, Liang Wu und 1 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c02873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Jiahui Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Glycoside Hydrolase Inhibitors, alpha-Glucosidases, Sulfonium Compounds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Shuang Chuang team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-Glucosidase inhibitors mitigate postprandial hyperglycemia by delaying carbohydrate hydrolysis. Guided by the principle of bioisosterism, we transformed an acid-labile benzylidene acetal sulfonium scaffold into acid-stable C-glycosyl pyranose–based sulfonium and selenonium salts. The lead, 38f, inhibited rat intestinal maltase and sucrase with IC 50 values of 0.10 and 0.08 μM, respectively, outperforming acarbose and voglibose, and showed excellent stability in simulated gastric fluid and intestinal fluid. In vivo, 38f delivered robust, dose-efficient glucose lowering: at 1–3 mg/kg, it markedly suppressed postprandial excursions in normal ICR mice and reduced fasting glucose in STZ-diabetic mice (3 mg/kg 32.8% vs acarbose 50 mg/kg 24.3%). Across OGTT/ITT and maltose/sucrose tolerance tests, 38f improved glycemic end points, liver glycogen, and HbA1c. Kinetic analyses support competitive inhibition of α-glucosidase. A 14-day subacute study (≤500 mg/kg) indicated an acceptable safety profile without hepatic or renal toxicity. These acid-resistant C-glycosyl pyranose cationic glycomimetics merit further development as antidiabetic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesSulfonium CompoundsOrganoselenium CompoundsAnimalsRatsMaleMiceMice, Inbred ICRStructure-Activity RelationshipDiabetes Mellitus, ExperimentalBlood GlucoseDrug DiscoveryHumans

Substanzen

Hypoglycemic AgentsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesSulfonium CompoundsOrganoselenium CompoundsBlood Glucose

Autor:innen und Institutionen

  • State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, P. R. China.
  • State Key Laboratory of Natural Medicines and Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, China.
  • Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon 16419, Korea.
  • Faculty of Pharmacy, Kinki University, 3-4-1 Kowakae, Higashi-osaka, Osaka 577-8502, Japan.
  • Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, P. R. China.

ORCID-Profile: Zhimei Wang, Wei Li, Genzoh Tanabe, Weijia Xie

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Jiangsu Shuang Chuang team

Zitieren

APA

Zhou, J., Jin, S., Yi, J., Li, Y., Tao, W., Li, Y., Wang, Z., Li, W., Jiang, H., Tanabe, G., Muraoka, O., Wu, L., & Xie, W. (2026). Discovery of Novel C-glycosyl Pyranose-Based Sulfonium and Selenonium Salts Targeting α-Glucosidase with Potent Antihyperglycemic Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02873

Vancouver

Zhou J, Jin S, Yi J, Li Y, Tao W, Li Y, et al. Discovery of Novel C-glycosyl Pyranose-Based Sulfonium and Selenonium Salts Targeting α-Glucosidase with Potent Antihyperglycemic Activity. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c02873

BibTeX
@article{Zhou2026,
  author = {Zhou, Jiahui and Jin, Shuqing and Yi, Jiahao and Li, Yaojia and Tao, Wenxiang and Li, Yu and Wang, Zhimei and Li, Wei and Jiang, Hulin and Tanabe, Genzoh and Muraoka, Osamu and Wu, Liang and Xie, Weijia},
  title = {Discovery of Novel C-glycosyl Pyranose-Based Sulfonium and Selenonium Salts Targeting α-Glucosidase with Potent Antihyperglycemic Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c02873}
}
Kostenlos starten →